The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Dry Powder Inhaler Market During The Forecast Period 2026–2030?
The dry powder inhaler market has experienced consistent expansion over recent years. This market is projected to expand from $22.18 billion in 2025 to $23.25 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.8%. Historically, this growth has been driven by factors such as the rising incidence of asthma and COPD, the extensive adoption of inhalation therapy, advancements in dry powder formulation technologies, the broadening scope of home-based respiratory care, and the accessibility of cost-effective inhaler devices.
The dry powder inhaler market size is projected to experience consistent expansion over the upcoming years. Its valuation is anticipated to reach $28.16 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.9%. This anticipated growth is largely driven by factors such as the increasing integration of smart inhaler technologies, a heightened emphasis on personalized respiratory care, the expansion of remote patient monitoring systems, a rising demand for environmentally conscious inhalers, and the broader adoption of digital health ecosystems. Key trends during this period are expected to encompass the growing uptake of digitally operated inhalers, an increasing need for monitoring patient adherence, a stronger focus on portable and user-friendly designs, the broadening of multi-dose inhaler platforms, and an elevated emphasis on ensuring dose accuracy.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13430&type=smp
Which Economic Or Industry Drivers Are Impacting The Dry Powder Inhaler Market?
The increasing incidence of respiratory diseases is anticipated to boost the growth of the dry powder inhaler market in the coming years. Respiratory diseases, also known as respiratory disorders or lung diseases, encompass a wide array of medical conditions affecting the respiratory system. Dry powder inhalers are vital for treating respiratory conditions such as asthma, COPD, and cystic fibrosis, as they effectively deliver medicine directly into the lungs where it is most potent. This method offers a promising alternative to traditional drug delivery approaches for respiratory diseases. For instance, in December 2023, a research study published by JAMA Network Open, a medical journal by the American Medical Association, projected that the global burden of chronic obstructive pulmonary disease (COPD) could lead to nearly 600 million cases worldwide by 2050, indicating a 23% increase in prevalence. Thus, the rising prevalence of respiratory diseases will propel the expansion of the dry powder inhaler market.
What Market Segments Are Evaluated Within The Dry Powder Inhaler Market?
The dry powder inhaler market covered in this report is segmented –
1) By Product: Single-Dose Inhalers, Multi-Dose Inhalers
2) By Function: Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices
3) By Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Other Applications
4) By End User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Single-Dose Inhalers: Capsule-Based Inhalers, Diskus-Based Inhalers
2) By Multi-Dose Inhalers: Blister-Based Inhalers, Rotahaler-Based Inhalers
What Industry Trends Are Redefining The Dry Powder Inhaler Market?
Major companies operating in the dry powder inhaler market are actively developing innovative products featuring muscarinic antagonists for treating chronic obstructive pulmonary disease (COPD) and are simultaneously expanding their product portfolios. A muscarinic antagonist is a medication that inhibits the muscarinic acetylcholine receptor, proving effective in controlling and treating various illnesses such as COPD and organophosphate poisoning. For instance, in March 2024, Berry Global, a US-based company renowned for its development and manufacturing of flexible packaging solutions, unveiled its new dry powder inhaler at Pharmapack, marking a strategic entry into advanced drug-delivery technologies. This device is engineered to improve the efficiency and consistency of drug delivery for respiratory conditions, particularly COPD and asthma, where precise dosing and ease of use are paramount. Its customizable design allows pharmaceutical companies to tailor the inhaler to specific formulation needs, thereby offering greater flexibility in product development. By combining patient-centric functionality with adaptable features, Berry Global aims to support innovation in the respiratory therapeutics space while strengthening its role as a partner for pharmaceutical manufacturers.
Who Are The Top Market Participants Influencing The Dry Powder Inhaler Market?
Major companies operating in the dry powder inhaler market are Novartis AG, AstraZeneca plc., GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, Viatris (Mylan N.V), Otsuka Pharmaceutical Co. Ltd, Catalent Inc., Aptar Group Inc., Chiesi Farmaceutici S.p.A., Recipharm AB, Cipla Limited, Lupin Limited, Orion Corporation, Hovione, MannKind Corporation, Presspart Manufacturing Ltd, Teva Pharmaceutical Industries Limited, Pharmaxis Ltd., Iconovo AB, SRS Pharmaceuticals Pvt. Ltd.
Read the full dry powder inhaler market report here:
https://www.thebusinessresearchcompany.com/report/dry-powder-inhaler-global-market-report
What Are The Top-Performing Regions Within The Dry Powder Inhaler Market?
North America was the largest region in the dry powder inhaler market in 2025. The regions covered in the dry powder inhaler market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Dry Powder Inhaler Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13430&type=smp
Browse Through More Reports Similar to the Global Dry Powder Inhaler Market 2026, By The Business Research Company
Digital Dose Inhalers Market Report 2026
https://www.thebusinessresearchcompany.com/report/digital-dose-inhalers-global-market-report
Inhalation And Nasal Spray Generic Drugs Market Report 2026
Respiratory Inhaler Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/respiratory-inhaler-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model